Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.

Hodgson DC, Hudson MM, Constine LS.

Semin Radiat Oncol. 2007 Jul;17(3):230-42. Review.

PMID:
17591570
2.

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.

Klimm B, Eich HT, Haverkamp H, Lohri A, Koch P, Boissevain F, Trenn G, Worst P, Dühmke E, Müller RP, Müller-Hermelink K, Pfistner B, Diehl V, Engert A; German Hodgkin Study Group.

Ann Oncol. 2007 Feb;18(2):357-63. Epub 2006 Oct 27.

3.
4.

A systematic overview of radiation therapy effects in Hodgkin's lymphoma.

Gustavsson A, Osterman B, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):589-604. Review.

PMID:
14596517
5.

Current approaches to the management of pediatric Hodgkin lymphoma.

Freed J, Kelly KM.

Paediatr Drugs. 2010 Apr 1;12(2):85-98. doi: 10.2165/11316170-000000000-00000. Review.

PMID:
20218745
7.

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM.

J Clin Oncol. 2008 Nov 10;26(32):5170-4. doi: 10.1200/JCO.2007.15.1001. Epub 2008 Oct 6.

8.
9.

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM.

J Clin Oncol. 2007 Jan 20;25(3):332-7.

10.

Favorable early-stage Hodgkin lymphoma.

Yahalom J.

J Natl Compr Canc Netw. 2006 Mar;4(3):233-40. Review.

PMID:
16507270
12.

Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?

Diehl V, Fuchs M; GHSG.

Transfus Apher Sci. 2007 Aug;37(1):37-41. Epub 2007 Aug 21. Review.

PMID:
17714996
13.

Combined modality treatment of Hodgkin's lymphoma.

Klimm B, Engert A.

Cancer J. 2009 Mar-Apr;15(2):143-9. doi: 10.1097/PPO.0b013e31819e31ba. Review.

PMID:
19390310
14.

Controversies in radiotherapy for pediatric Hodgkin's lymphoma.

Wiegner EA, Donaldson SS.

Expert Rev Anticancer Ther. 2011 Sep;11(9):1357-66. Review.

PMID:
22029056
15.

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.

Ai Zheng. 2007 Dec;26(12):1360-4. Chinese.

PMID:
18076802
16.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
17.

First-line treatment of Hodgkin's lymphoma.

Klimm B, Engert A, Diehl V.

Curr Hematol Rep. 2005 Jan;4(1):15-22. Review.

PMID:
15610655
18.

[Modern pharmacotherapy of Hodgkin disease].

Josting A, Behringer K, Engert A, Diehl V.

Internist (Berl). 2004 Jan;45(1):93-101. Review. German.

PMID:
14735247
19.

Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.

Hoppe BS, Moskowitz CH, Filippa DA, Moskowitz CS, Kewalramani T, Zelenetz AD, Yahalom J.

J Clin Oncol. 2008 Apr 10;26(11):1858-64. doi: 10.1200/JCO.2007.15.4773. Epub 2008 Mar 10. Erratum in: J Clin Oncol. 2008 Aug 20;26(24):4053. Zelenet, Andrew D [corrected to Zelenetz, Andrew D].

20.

Does radiotherapy still have a place in Hodgkin lymphoma?

Yahalom J.

Curr Hematol Malig Rep. 2009 Jul;4(3):117-24. doi: 10.1007/s11899-009-0017-2. Review.

PMID:
20425424
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk